G Paul Amminger is an expert in Psychiatry at University of Melbourne (Australia). As of October 2026, ScienceLeadR ranks G Paul Amminger in the top 1% of experts worldwide for Psychotic Disorders and Schizophrenia Spectrum and Other Psychotic Disorders. G Paul Amminger has authored 308 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 797 (community average: 125). How the SLR is computed.

LeadR Profile

G Paul Amminger University of Melbourne Australia
797 ScienceLeadR Reputation 797
Network Map

Psychiatry

Subspecialties: Pediatrics - Public Health - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Melbourne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 308

Citations

Citations: 17 007 1st author: 39 Last author: 69 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Association between polygenic liability to depression and lifetime depression in at-risk adolescents.
PMID 42839001 — depression, molecular biology, mental disorders, signs and symptoms, depressive disorder, adolescent, neurosciences, depressive disorder, major
Mol Psychiatry20260
Machine Learning Prediction of First Suicide Attempts in Early Adolescence Among Child Ideators.
PMID 42562219 — child psychiatry, brain, machine learning, sex, learning, phobia, social, impulsive behavior, suicidal ideation, adolescent psychiatry, suicide, attempted, child, suicide, generalized anxiety disorder
J Am Acad Child Adolesc Psychiatry20260
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis.
PMID 42459164 — sleep, stress, physiological, signs and symptoms, accounting, psychotic disorders, suicidal ideation, suicide
Schizophr Bull Open20260
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis.
PMID 42383294 — biomarkers, signs and symptoms, schizophrenia, smoking, psychotic disorders
Early Interv Psychiatry20260
The Staging Model in Psychosis and Preventive Interventions: An Emerging Field With Debates on Conceptual Models and Interpretation of the Evidence Base.
PMID 42328781 — classification, signs and symptoms, research, psychotic disorders, cognitive behavioral therapy, psychiatry
Early Interv Psychiatry20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 1
Phase 4 1

By status:

Completed 2

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map